Powell, OH, United States of America

Matthew Ohr

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: The Ohio State University. Active years: 2023-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew Ohr. Retrieved from https://idiyas.com/inventor/matthew-ohr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Matthew Ohr in Ocular Drug Delivery

Introduction

Matthew Ohr is an accomplished inventor based in Powell, OH (US). He has made significant contributions to the field of ocular drug delivery, holding 3 patents that focus on innovative methods and compositions for sustained release microparticles.

Latest Patents

One of Matthew Ohr's latest patents is titled "Methods and compositions for sustained release microparticles for ocular drug delivery." This patent describes compositions, devices, and processes designed for effective drug delivery to the eye. The disclosed drug delivery compositions consist of a particle with a core component made of a first polymer and a therapeutic agent, surrounded by a shell layer composed of a second polymer. Additionally, the patent outlines methods for treating ophthalmological diseases or disorders, providing a comprehensive approach to ocular health.

Career Highlights

Matthew Ohr is associated with the Ohio State Innovation Foundation, where he continues to develop and refine his innovative ideas. His work focuses on enhancing the efficacy of drug delivery systems, particularly in the field of ophthalmology.

Collaborations

Matthew has collaborated with notable colleagues, including Pengfei Jiang and Katelyn Elizabeth Reilly, contributing to the advancement of research and development in ocular drug delivery.

Conclusion

Matthew Ohr's innovative work in ocular drug delivery showcases his commitment to improving healthcare solutions. His patents reflect a deep understanding of the complexities involved in drug delivery systems, making significant strides in the treatment of eye-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…